THE SYMPTOMATIC RELIEF OF ANXIETY WITH MEPROBAMATE, PHENOBARBITAL AND PLACEBO
Abstract
Fifty-two pychoneurotic outpatients with anxiety symptoms were treated in a controlled clinical study with meprobamate 400 mg. q.i.d., phenobarbital 16 mg. q.i.d. and placebo q.i.d. The patients were divided into 2 comparable groups of 26, each group treated by a different psychiatrist. In the combined population of 52 patients, no significant differences appeared in the effectiveness of the 3 agents. The data then were analyzed for each psychiatrist's group separately. In one psychiatrist's group, the 3 agents were equally effective. In the other psychiatrist's group, the 2 active drugs were equally effective, but superior to placebo.
Differences in the expectations of the 2 psychiatrists are discussed as a possible factor in these results, despite successful operation of the "double-blind" technique.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
